Please note that Gilead Medical Information will forward the reports to our Drug Safety and Public Health Department, which in certain circumstances may contact you for more information about a report.
Gilead Sciences Ltd consistently collates and reviews product safety information received from clinical trials and post-marketing activities. The information received is evaluated on an on-going basis ensuring the continuous surveillance of Gilead Sciences Ltd products.
Date of preparation: August 2018
This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.